Analgesia Nociception Index in Orthognathic Surgery
Comparison of Goal-directed Analgesia Using ANI (Analgesia/Nociception Index) and Standard Analgesia During General Anesthesia in Patients Undergoing Orthognathic Surgery on Postoperative Quality of Recovery: a Prospective Randomized Controlled Trial
1 other identifier
interventional
86
1 country
1
Brief Summary
This study aims to determine whether goal-directed analgesia using ANI(Analgesia/Nociception Index) can improve the quality of postoperative recovery in patients undergoing maxillofacial surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable postoperative-pain
Started Jan 2024
Longer than P75 for not_applicable postoperative-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 13, 2023
CompletedFirst Posted
Study publicly available on registry
January 16, 2024
CompletedStudy Start
First participant enrolled
January 25, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 25, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 30, 2026
January 16, 2024
January 1, 2024
2.9 years
December 13, 2023
January 12, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Postoperative QoR-15K score
Korean-translated QoR-15K (15-item Quality of Recovery (QoR-15) scale, minimum 0, maximum 150, higher scores mean a better outcome ) scores assessed by participants blinded to arm assignment 24 hours after surgery.
24 hours after the end of surgery
Secondary Outcomes (14)
Patient satisfaction
24 hours after the end of surgery
intraoperative opioid consumption
during surgery
intraoperative non-opioid consumption
during surgery
intraoperative use of vasoactive drugs
during surgery
The time-weighted average of the segments of the total anesthesia time where the ANI value did not remain above 50 and below 70.
during surgery
- +9 more secondary outcomes
Study Arms (2)
goal-directed analgesia using ANI monitoring
EXPERIMENTALStandard monitoring
ACTIVE COMPARATORInterventions
intraoperative analgesia was provided by infusion of remifentanil via target controlled infusion mode, which was controlled according to ANI monitor.
intraoperative analgesia was provided by infusion of remifentanil via target controlled infusion mode, which was controlled according to the clinician's decision
Eligibility Criteria
You may qualify if:
- Adult patients 18 or older undergoing maxillary, mandibular, or bimaxillary surgery under general anesthesia.
- adult patients who can provide written informed consent to participate in the study, understand the procedures of this study, and be able to complete patient-reported questionnaires adequately.
- adult patients who Have made an informed decision to participate in this study and have given written consent.
You may not qualify if:
- Patients with ASA physical status 4-5
- Emergency surgery
- Patients with chronic pain and related pain medications
- Patients with hypersensitivity to general anesthesia drugs and pain medications
- Patients with arrhythmia
- Pregnant women
- Others deemed unsuitable by the investigator
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Seoul National University Children's Hospital
Seoul, 03080, South Korea
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- professor
Study Record Dates
First Submitted
December 13, 2023
First Posted
January 16, 2024
Study Start
January 25, 2024
Primary Completion (Estimated)
December 25, 2026
Study Completion (Estimated)
December 30, 2026
Last Updated
January 16, 2024
Record last verified: 2024-01